Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,866,678 | $1,239,359 | $1,538,487 | $1,986,904 |
| - Cash | $76,247 | $88,205 | $139,259 | $203,126 |
| + Debt | $56,988 | $71,996 | $85,659 | $97,094 |
| Enterprise Value | $1,847,419 | $1,223,150 | $1,484,887 | $1,880,872 |
| Revenue | $36,498 | $26,823 | $14,240 | $0 |
| % Growth | 36.1% | 88.4% | – | – |
| Gross Profit | $32,333 | $17,319 | $12,536 | -$18,777 |
| % Margin | 88.6% | 64.6% | 88% | – |
| EBITDA | -$420,084 | -$384,864 | -$380,483 | -$337,733 |
| % Margin | -1,151% | -1,434.8% | -2,671.9% | – |
| Net Income | $673,725 | -$352,088 | -$231,801 | $1,604,715 |
| % Margin | 1,845.9% | -1,312.6% | -1,627.8% | – |
| EPS Diluted | 11.64 | -6.33 | -4.23 | -6.36 |
| % Growth | 283.9% | -49.6% | 33.5% | – |
| Operating Cash Flow | -$389,841 | -$296,062 | -$309,478 | -$407,320 |
| Capital Expenditures | -$1,685 | -$999 | -$4,881 | -$5,741 |
| Free Cash Flow | -$391,526 | -$297,061 | -$314,359 | -$413,061 |